Exhibitor

Where Quality Meets Genomic Innovation

Source Genomics, part of the Source BioScience group, delivers genomic and multi-omic services designed to accelerate innovation with high-quality, reliable solutions. 

Leveraging over two decades of expertise in genomic sequencing and the latest technological advancements, the company provides a comprehensive range of services to support early-stage R&D, translational research, clinical trials, and clinical diagnostics. These services cover advanced molecular testing, assay development, biomarker validation, and fully accredited laboratory operations, enabling a seamless transition from discovery to clinical application and accelerating progress along the research-to-diagnostics pipeline.

The recent acquisition of Cambridge Clinical Laboratories (CCL), a Cambridge-based leader in personalised healthcare testing, expands Source Genomics’ clinical diagnostics capabilities. CCL provides specialist solutions across oncology, virology, and hereditary conditions, along with validation studies for clinical research. This acquisition strengthens Source Genomics’ end-to-end laboratory services, integrating biomarker-driven genomic testing with established clinical histopathology operations to deliver a comprehensive offering.